HN1997000045A - Nuevos pirimido (1, 2 - 0) indoles - Google Patents

Nuevos pirimido (1, 2 - 0) indoles

Info

Publication number
HN1997000045A
HN1997000045A HN1997000045A HN1997000045A HN1997000045A HN 1997000045 A HN1997000045 A HN 1997000045A HN 1997000045 A HN1997000045 A HN 1997000045A HN 1997000045 A HN1997000045 A HN 1997000045A HN 1997000045 A HN1997000045 A HN 1997000045A
Authority
HN
Honduras
Prior art keywords
pirimido
indoles
new
present
invention refers
Prior art date
Application number
HN1997000045A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of HN1997000045A publication Critical patent/HN1997000045A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

LA PRESENTE INVENCION SE REFIERE A
HN1997000045A 1996-04-04 1997-04-04 Nuevos pirimido (1, 2 - 0) indoles HN1997000045A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19613550A DE19613550A1 (de) 1996-04-04 1996-04-04 Neue Pyrimido[1,2-a]indole

Publications (1)

Publication Number Publication Date
HN1997000045A true HN1997000045A (es) 1997-06-26

Family

ID=7790502

Family Applications (1)

Application Number Title Priority Date Filing Date
HN1997000045A HN1997000045A (es) 1996-04-04 1997-04-04 Nuevos pirimido (1, 2 - 0) indoles

Country Status (33)

Country Link
US (1) US6114341A (es)
EP (1) EP0799828A3 (es)
JP (1) JPH1059972A (es)
KR (1) KR970070008A (es)
CN (2) CN1067393C (es)
AR (1) AR006497A1 (es)
AU (1) AU725786B2 (es)
BG (1) BG62934B1 (es)
BR (1) BR9701675A (es)
CA (1) CA2201434A1 (es)
CO (1) CO4520306A1 (es)
CZ (1) CZ102297A3 (es)
DE (1) DE19613550A1 (es)
DZ (1) DZ2201A1 (es)
EE (1) EE9700078A (es)
HN (1) HN1997000045A (es)
HR (1) HRP970154A2 (es)
HU (1) HUP9700708A3 (es)
ID (1) ID16520A (es)
IL (3) IL120590A (es)
MA (1) MA24131A1 (es)
MY (1) MY126362A (es)
NO (1) NO309092B1 (es)
NZ (1) NZ314497A (es)
PE (1) PE42398A1 (es)
PL (1) PL319249A1 (es)
SG (1) SG63698A1 (es)
SK (1) SK42797A3 (es)
SV (1) SV1997000025A (es)
TN (1) TNSN97061A1 (es)
TR (1) TR199700261A2 (es)
YU (1) YU12397A (es)
ZA (1) ZA972829B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19826469A1 (de) * 1998-06-13 2000-05-25 Bayer Ag Verfahren zur Herstellung von 2,4-Dimethylcarbolin und 2,4-Dimethylpyrimido[1,2-a]indol
WO2001074817A1 (fr) * 2000-03-30 2001-10-11 Yamanouchi Pharmaceutical Co., Ltd. Derives d'hydrazide
DE10030375A1 (de) * 2000-06-21 2002-01-03 Bayer Ag Verwendung von MTP-Inhibitoren zur Senkung von ppTRL
JP4254093B2 (ja) * 2001-10-17 2009-04-15 宇部興産株式会社 ５−ハロゲノインドールの製法
DE10349175A1 (de) * 2003-10-22 2005-05-19 Bayer Healthcare Ag Mittel zur Gewichtsreduktion
US7932268B2 (en) 2004-03-05 2011-04-26 The Trustees Of The University Of Pennsylvania Methods for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimizing side effects
CA2562015A1 (en) * 2004-04-09 2005-10-20 Janssen Pharmaceutica Nv Intermittent dosing regimens of apob secretion/mtp inhibitors for overweith and obese subjects
JP5102201B2 (ja) 2005-05-12 2012-12-19 シー・アール・バード・インコーポレーテッド 取り外し可能な塞栓血餅フィルタ
EP1890767A2 (en) * 2005-05-27 2008-02-27 Pfizer Products Inc. Combination of a cannabinoid-1- receptor-antagonist and a microsomal triglyceride transfer protein inhibitor for treating obesity or mainataining weight loss
JP4851522B2 (ja) 2005-08-09 2012-01-11 シー・アール・バード・インコーポレーテッド 挿入型血栓フィルタ及びデリバリシステム
AU2006304531A1 (en) * 2005-10-18 2007-04-26 Aegerion Pharmaceuticals Methods for treating disorders associated with hyperlipidemia in a mammal
WO2007133366A2 (en) 2006-05-02 2007-11-22 C. R. Bard, Inc. Vena cava filter formed from a sheet
EP2120927A1 (en) * 2006-12-21 2009-11-25 Aegerion Pharmaceuticals, Inc. Methods for treating obesity with a combination comprising a mtp inhibitor and a cholesterol absorption inhibitor

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2200584A1 (de) * 1971-01-11 1972-07-27 Wyeth John & Brother Ltd Heterocyclische Verbindungen,Verfahren zu ihrer Herstellung und ihre Verwendung in pharmazeutischen Zubereitungen
ZA718536B (en) * 1971-01-11 1972-09-27 Wyeth John & Brother Ltd Heterocyclic compounds
GB8614246D0 (en) * 1986-06-11 1986-07-16 Wyeth John & Brother Ltd Substituted pyrimidoindoles
DE4112533A1 (de) * 1991-04-17 1992-10-22 Bayer Ag Verfahren zur herstellung von enantiomerenreinen substituierten (chinolin-2-yl-methoxy)phenyl-essigsaeuren
DE4200954A1 (de) * 1991-04-26 1992-10-29 Bayer Ag Heterocyclisch substituierte phenylessigsaeurederivate
US5576342A (en) * 1992-03-13 1996-11-19 Bayer Aktiengesellschaft Phenylglycinamides of heterocyclically substitued phenylacetic acid derivatives
DE4208052A1 (de) * 1992-03-13 1993-09-16 Bayer Ag Imidazolyl substituierte phenylessigsaeureamide
DE4309968A1 (de) * 1993-03-26 1994-09-29 Bayer Ag Phenylglycinamide von heterocyclisch substituierten Phenylessigsäurederivaten
DE4208051A1 (de) * 1992-03-13 1993-09-16 Bayer Ag Substituierte phenylessigsaeureamide
JPH08502741A (ja) * 1992-11-05 1996-03-26 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー ５−ｈｔ▲下４▼レセプターアンタゴニスト用のピペリジン誘導体
DE4302956A1 (de) * 1993-02-03 1994-08-04 Bayer Ag Substituierte Imidazo(4,5-b)pyridine und Benzimidazole

Also Published As

Publication number Publication date
DZ2201A1 (fr) 2002-12-03
IL131645A0 (en) 2001-01-28
CO4520306A1 (es) 1997-10-15
SV1997000025A (es) 1997-10-23
HUP9700708A2 (hu) 1998-10-28
EP0799828A2 (de) 1997-10-08
NZ314497A (en) 1999-10-28
SK42797A3 (en) 1997-11-05
EP0799828A3 (de) 1998-04-08
NO971512L (no) 1997-10-06
IL120590A (en) 2000-02-17
US6114341A (en) 2000-09-05
NO309092B1 (no) 2000-12-11
CN1067393C (zh) 2001-06-20
AR006497A1 (es) 1999-08-25
ID16520A (id) 1997-10-09
HUP9700708A3 (en) 2000-01-28
SG63698A1 (en) 1999-03-30
HU9700708D0 (en) 1997-05-28
CA2201434A1 (en) 1997-10-04
JPH1059972A (ja) 1998-03-03
MX9702445A (es) 1997-10-31
CN1176965A (zh) 1998-03-25
NO971512D0 (no) 1997-04-03
CN1312246A (zh) 2001-09-12
IL120590A0 (en) 1997-08-14
AU1660397A (en) 1997-10-09
CZ102297A3 (en) 1997-10-15
IL131645A (en) 2000-12-06
TNSN97061A1 (fr) 2005-03-15
YU12397A (en) 1999-11-22
BR9701675A (pt) 1998-11-03
BG62934B1 (bg) 2000-11-30
PL319249A1 (en) 1997-10-13
ZA972829B (en) 1997-10-31
BG101379A (en) 1997-11-28
HRP970154A2 (en) 1998-04-30
AU725786B2 (en) 2000-10-19
PE42398A1 (es) 1998-10-12
TR199700261A2 (xx) 1997-10-21
KR970070008A (ko) 1997-11-07
DE19613550A1 (de) 1997-10-09
MY126362A (en) 2006-09-29
MA24131A1 (fr) 1997-10-01
EE9700078A (et) 1997-10-15

Similar Documents

Publication Publication Date Title
HN1999000155A (es) 4-carboxiamino-2-metil-1,2,3,4-tetrahidroquinolinas
HN1997000040A (es) Sal mesilatotrihidroto de 5-2-4-1,2 -benzoisotiazol -3 il 1- piperazinil etil -6 - cloro 13 dihidro 2h indol 2-ona.
HN1997000126A (es) Derivados de indazol
HN1997000023A (es) Derivados de lactama
HN1997000097A (es) Piridinas condensadas con heterociclicos
HN1998000175A (es) Imidazotriazininas
HN1997000090A (es) Compuestos de piridilpirrol
HN1996000124A (es) 2-ox y 2- tio - 1, 2 dihidroquinolinil oxazolidinonas
HN1999000154A (es) 1,2,3,4 tetrahidroquinolinas 2 sustituidas 4 - carboxiamino sustituidas.
HN1997000083A (es) Derivados triciclicos sustituidos con fenilamino
HN1997000166A (es) 1-arilpirazoles plaguicidas
HN1997000149A (es) Derivados de 6 fenilpiridil 2 amina
HN1999000125A (es) Nuevos derivados sustituidos del pirazol
HN1998003689A (es) Azetidinas
HN1998000124A (es) Terapia de combinacion
HN1998000030A (es) 2-amino-6-(4fenoxi-2-sustituido)-piridinas sustituidas
HN1997000045A (es) Nuevos pirimido (1, 2 - 0) indoles
HN1998000158A (es) Isoquinolinas
HN1998000028A (es) Otropisomeros de 3 heteroaril - 4 (3h) - quinazolinonas.
HN1998000106A (es) Composiciones parenterales de alatroflaxacino
HN1998000193A (es) Compuestos de triazina
HN1997000094A (es) Variante de apratinina con propiedades mejoradas
ES2164292T3 (es) Iminooxadiazindionas policiclicas a partir de 1,4-diisocianatos(ciclo)alifaticos.
HN1997000013A (es) Compuestos 1,4 dihidropiridina
HN1998000165A (es) Polimorfos dofetilina